Condition
Sciatica Acute
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (1)
P 4 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07397117Not ApplicableRecruitingPrimary
Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care
NCT07588126Not ApplicableCompletedPrimary
Ultrasound-guided Transgluteal Sciatic Nerve Hydrodissection for the Treatment of Sciatica in the Emergency Department
NCT06157177Phase 4RecruitingPrimary
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
NCT07161323Not ApplicableRecruiting
SNAG and SNME in Non-Specific Sciatic Pain
NCT05626140Phase 3CompletedPrimary
COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA
Showing all 5 trials